Podcasts by Open Heart podcast

A balanced omega-6/omega-3 ratio in the Greek Diet: the powerful aid in fighting obesity from 2016-10-03T17:12:27

The truths and myths about the relationship between omega-6 and omega-3 intake and prevention of obesity are revealed in this podcast. The Editor in Chief of Open Heart, Pascal Meier, interviews A...

Why we were wrong about dietary fat guidelines from 2015-02-05T14:27:07

Rahul Bahl, Open Heart associate editor, talks to Zoe Harcombe about her article: Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 an...

CDIS 2014: Tackling global reimbursement considerations: How does this impact trial design? from 2014-02-03T14:15:29

By Perry Bridger.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the prog...

CDIS 2014: Commissioning through evaluation, and streamlining the commissioning process from 2014-02-03T14:14:04

By Wayne Bartlett-Syree and Mark de Belder.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collabor...

CDIS 2014: New technology appraisal and commissioning discussion from 2014-02-03T14:12:31

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the programme here: bit.ly/1ghpx...

CDIS 2014: Summit summary and closing comments from 2014-02-03T14:10:15

With John Martin.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the prog...

CDIS 2014: Inside NICE: Defining cost effectiveness and technology assessment from 2014-02-03T14:09:12

By Mirella Marlow.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the pro...

CDIS 2014: Funding opportunities from the British Heart Foundation from 2014-02-03T14:07:17

By Peter Weissberg, medical director, British Heart Foundation.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by t...

CDIS 2014: NIH initiatives - early stage funding opportunities for device innovation from 2014-02-03T14:02:14

By Jodi Black, deputy director, Office of Translational Alliances and Coordination, NIH.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summi...

CDIS 2014: Innovation: Preclinical and imaging in device iteration discussion from 2014-01-30T15:15:07

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the programme here: bit.ly/1ghpx...

CDIS 2014: Preclinical evaluation case examples: How pathologists can streamline device development from 2014-01-30T15:10:42

By Michael Joner.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the prog...

CDIS 2014: Neurodeflection for TAVI: Establishing clinical need and approval pathway from 2014-01-30T12:14:24

By Pauliina Margolis, Keystone Heart.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative....

CDIS 2014: Intellectual property disasters I have lived through and you should avoid from 2014-01-30T12:07:18

By Maurice Buchbinder.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the...

CDIS 2014: Implementing EMA guidelines for DES CE approval from 2014-01-30T12:05:35

With Bart Segers and Christine Shan.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.<...

CDIS 2014: Can regulators facilitate innovation while balancing responsibilities for patient safety? from 2014-01-30T11:39:34

By Ian Hudson, chief executive Medicines and Healthcare Product Regulatory Agency.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, Jan...

CDIS 2014: British healthcare policy and funding for MedTech discussion from 2014-01-30T11:34:58

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the programme here: bit.ly/1ghpx...

CDIS 2014: Targeted biologics: The future of medicine, innovation, and interventional therapeutics from 2014-01-30T11:33:31

By John Martin.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the progra...

CDIS 2014: Can the UK gain a competitive edge in BioTech? Role, goals, and challenges of NOCRI from 2014-01-30T11:31:19

By Mark Samuels, managing director, NIHR Office for Clinical Research Infrastructure.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, ...

CDIS 2014: British health care policy in a global landscape from 2014-01-30T11:26:56

By Julian Huppert, Lib Dem MP for Cambridge.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collabo...

CDIS 2014: The Yale-UCL Research and Device Evaluation Program: A trans atlantic academic initiative from 2014-01-30T10:56:20

By Alexandra Lansky.

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative.

View the p...

CDIS 2014: British healthcare policy and funding for MedTech introduction from 2014-01-30T10:52:33

With John Martin and Bryan Williams.

Session goals:

- CV innovation as a major goal of British National interest

- Goals of MedTech in the EU/US trade and investment partnershi...

Replacing saturated fats: Are the guidelines wrong? from 2014-01-23T09:59:05

Editor-in-chief Pascal Meier talks to James DiNicolantonio, Wegmans Pharmacy, Ithaca, NY, about his article examining guidelines on the cardiometabolic consequences of replacing saturated fats w...

COPD and mortality after acute myocardial infarction from 2013-12-17T15:29:36

Dr Pascal Meier, MD, Editor-in-Chief of the new BMJ cardiology journal Open Heart, is discussing a paper on the impact of chronic obstructive pulmonary disease COPD on clinical outcomes in patie...